UK OTC Market Bounces Back In 2021 With Help Of Cold, Flu And Pain Categories

Thanks to double-digit growth in the cold and flu category and higher demand for analgesics, the UK’s OTC market grew by 4.5% to £2.87bn ($3.52bn), according to data from NielsenIQ. Looking ahead, Nielsen's consumer health expert Matt Carpenter suggests that consumers are now adopting "moving on" mindsets, which OTC firms need to take into account in their business strategies.

Pill capsule with Great Britain flag. UK health care concept, 3D rendering
• Source: Shutterstock

The return of seasonal viruses, together with the emergence of the Omicron variant of the coronavirus, drove up demand for OTC cold, flu and pain products at the end of last year, helping the UK’s consumer health market rebound in 2021, according to NielsenIQ.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from United Kingdom

More from Europe